Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy
To access this article, please choose from the options below
J. A. E., A. S., and M. R. P. have no conflicts of interest to declare. P. W. A., C. B. G., R. J. K., and P. T. received research grants from the trial sponsors.
PII: S0002-8703(10)00441-2
doi:10.1016/j.ahj.2010.05.035
© 2010 Mosby, Inc. All rights reserved.
